View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Upcoming Pharmaceutical Courses from NSF

NSF has announced a wide range of upcoming courses related to the pharmaceutical industry. Make sure you remember to take advantage of any discounts you could be entitled to. Get in touch if you’re interested in bringing any of this training on-site.

  • Incident Management Workshop – 11 September (Stansted, UK)
  • Human Error Prevention Workshop – 12 September to 13 September (Stansted, UK)
  • Pharmaceutical good manufacturing practices (GMP) audits and self-Inspections (a Chartered Quality Institute (CQI) and International Register of Certificated Auditors (IRCA) certified GMP Personnel Qualification Standard (PQS) lead auditor course) – 17 September to 21 September (York, UK) and 22 october to 26 October (Hamburg, Germany)
  • Quality Risk Management – 25 September to 26 September (Manchester, UK)
  • Pharmaceutical Legislation Update – 2 October (York, UK)
  • Good distribution practice (GDP) and Materials Management Workshop – 9 October to 10 October (Watford, UK)
  • Good clinical practice (GCP) Workshop – 10 October (Watford, UK)
  • Good pharmacovigilance practice (GVP) Workshop – 11 October (Watford, UK)
  • Pharmaceutical Law and Administration QP Module – 15 October to 19 October (York, UK)
  • A-Z of Sterile Products Manufacture – 29 October – 2 November (Amsterdam, The Netherlands)
  • Internal Auditor Training Workshop – 30-31 October (Watford, UK)

Looking to plan further ahead?

Find out more information by making an enquiry using the form on this page and register online to attend.

Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology